Adenocarcinoma, Bronchiolo-Alveolar
Latest Paper:
Dawn M Flaherty,
Sara L Hinde,
Martha M Monick,
Linda S Powers,
Mary A Bradford,
Timur Yarovinsky,
Gary W Hunninghake
Airway epithelial cells are often the sites of targeted adenovirus vector delivery. Activation of the host inflammatory response and modulation of signal transduction pathways by adenovirus vectors have been previously documented, including activation of MAP kinases and phosphatidylinositol 3-kinase (PI3-kinase). The effect of activation of these pathways by adenovirus vectors on cell survival has not been examined. Both the PI3-kinase/Akt and ERK/MAP kinase signaling pathways have been linked to cell survival. Akt has been found to play a role in cell survival and apoptosis through its downstream effects on apoptosis-related proteins. Constitutive activation of either PI3-kinase or Akt blocks apoptosis induced by c-Myc, UV radiation, transforming growth factor-beta, Fas, and respiratory syncytial virus infection. We examined the effect of adenovirus vector infection on activation of these prosurvival pathways and its downstream consequences. Airway epithelial cells were transduced with replication-deficient adenoviral vectors containing a nonspecific transgene, green fluorescent protein driven by the cytomegalovirus promoter, or an empty vector with no transgene. They were then exposed to the proapoptotic stimulus actinomycin D plus TNF-alpha, and evidence of apoptosis was evaluated. Compared with the cells treated with actinomycin/TNF alone, the adenovirus vector-infected cells had a 50% reduction in apoptosis. When we examined induction of the prosurvival pathways, ERK and AKT, in the viral vector-infected cells, we found that there was significant activation of both Akt and ERK.
Mesh-terms: Adenocarcinoma, Bronchiolo-Alveolar; Adenoviridae :: genetics; Antineoplastic Agents :: pharmacology; Apoptosis :: drug effects; Apoptosis :: physiology; Cell Line, Tumor; Cell Survival :: physiology; Gene Expression Regulation, Viral; Genetic Vectors :: physiology; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinases :: metabolism; Protein-Serine-Threonine Kinases :: metabolism; Proto-Oncogene Proteins :: metabolism; Proto-Oncogene Proteins c-akt; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S. ; Respiratory Mucosa :: cytology; Respiratory Mucosa :: physiology; Transcription, Genetic; Tumor Necrosis Factor-alpha :: pharmacology;
Most cited papers:
Ontario Cancer Institute, University of Toronto, Canada.
Elevated levels of insulin-like growth factor (IGF)-II are associated with a poor prognosis in human pulmonary adenocarcinoma; however, a causal role for IGF-II in pulmonary adenocarcinoma has not been demonstrated. Here, we show that transgenic overexpression of IGF-II in lung epithelium induces lung tumors in 69% of mice older than 18 months of age. These tumors displayed morphological characteristics of human pulmonary adenocarcinoma such as their epithelial origin, tubulo-acinar architecture and expression of TTF-1, SP-B and proSP-C. Examination of signaling molecules downstream of the IGF-IR showed the activation of either the Erk1/Erk2 or p38 MAPK pathways, but not both, within the lung tumors. Notably, all lung tumors contained high levels of phosphorylated CREB, suggesting that both the Erk1/Erk2 and p38 MAPK pathways converged on this transcription factor. Moreover, IGF-II induced proliferation and CREB phosphorylation in human lung cancer cell lines, suggesting that IGF-II and CREB also contribute to the growth of human lung tumors. Thus, IGF-II is an important genetic factor in the development of lung tumorigenesis, in which activation of CREB is a ubiquitous event. The MMTV-IGF-II transgenic mice provide a critical model for elucidating the role of IGF-II in this fatal human disease.
Mesh-terms: Adenocarcinoma, Bronchiolo-Alveolar; Animals; DNA-Binding Protein, Cyclic AMP-Responsive :: metabolism; Disease Models, Animal; Human; Humans; Immunohistochemistry; Insulin-Like Growth Factor II :: biosynthesis; Insulin-Like Growth Factor II :: genetics; Lung Neoplasms :: etiology; Lung Neoplasms :: genetics; Mice; Mice, Transgenic; Signal Transduction :: physiology;
Department of Pediatrics, Case Western Reserve University and Rainbow Babies and Children's Hospital, Cleveland, Ohio 44106, USA.
The expression of the inducible form of nitric oxide synthase (NOS2) is reduced in cystic fibrosis (CF) epithelium despite the presence of aggressive inflammation. A potential mechanism for reduced NOS2 expression in CF is diminished signal transducer and activator of transcription-1 (STAT1) activity, possibly due to an increase in expression of protein inhibitor of activated STAT1 (PIAS1). Previous evidence also suggests that NOS2 expression can be negatively regulated by increased activation of the GTPase RhoA, leading to the hypothesis that CF-related increases in PIAS1 expression and altered STAT1 signaling may be mediated by Rho GTPase function. Consistent with this hypothesis, data demonstrate increased expression of RhoA in two models of CF epithelium with a proportional increase in the active GTP-bound RhoA. Mouse embryonic fibroblasts null for p190B Rho GTPase-activating protein exhibit increased RhoA protein content and activation, similar to what is observed in CF models, and also exhibit CF-like alterations in STAT1 regulation, including decreased STAT1 activation, increased PIAS1 protein expression, and reduced NOS2 induction, implicating RhoA-mediated signaling in CF-related STAT1 alterations. Inhibition of the Rho GTPase pathway at the level of isoprenoid/cholesterol synthesis with mevastatin reduces PIAS1 expression, increases STAT1 activation, and restores NOS2 expression in models of CF epithelium, suggesting that pharmacological inhibition of the isoprenoid synthesis/Rho GTPase pathway may represent a potential avenue for therapeutic intervention for CF.
Mesh-terms: Adenocarcinoma, Bronchiolo-Alveolar; Anticholesteremic Agents :: pharmacology; Cell Line, Tumor; Cholesterol :: biosynthesis; Cystic Fibrosis :: metabolism; Cystic Fibrosis :: physiopathology; DNA-Binding Proteins :: metabolism; Gene Expression Regulation, Enzymologic; Human; Lovastatin :: analogs & derivatives; Lovastatin :: pharmacology; Lung Neoplasms; Nitric-Oxide Synthase :: genetics; Proteins :: genetics; Proteins :: metabolism; Respiratory Mucosa :: cytology; Respiratory Mucosa :: metabolism; Respiratory Mucosa :: physiopathology; Signal Transduction :: drug effects; Signal Transduction :: physiology; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S. ; Terpenes :: metabolism; Trans-Activators :: metabolism; rhoA GTP-Binding Protein :: genetics; rhoA GTP-Binding Protein :: metabolism;
Department of Environmental Medicine, New York University School of Medicine, Tuxedo 10987, USA.
Ozone is one of the most common air pollutants humans routinely inhale. We have previously shown that in vitro ozone exposure induces the DNA-binding activities of NF-kappaB and NF-IL6 as well as the expression of interleukin 8 in respiratory epithelial cells. In this study, we investigated intracellular signaling steps mediating ozone-induced inflammatory mediator release. A549 cells, a type II like alveolar epithelial cell line, were exposed in vitro to air or 0.1 ppm of ozone in the presence of several kinase inhibitors. Exposure to ozone increased interleukin 8 expression and transcription factor activities in a protein tyrosine kinase (PTK)-dependent and protein kinase A (PKA)-dependent, yet protein kinase C (PKC)-independent, manner. Furthermore, ozone-induced PTK and PKA activities but failed to induce PKC activity. In addition, our results suggest that ozone-induced PTK and PKA activities were reactive oxygen intermediate dependent and occurred in parallel, because specific inhibitors for PTK and PKA failed to block the other kinase's activity. These results indicate that PTK and PKA activities are early events in the signal transduction cascade mediating the ozone-induced activation of NF-kappaB and NF-IL6 as well as the release of interleukin 8.
Mesh-terms: Adenocarcinoma, Bronchiolo-Alveolar; CCAAT-Enhancer-Binding Proteins; Cyclic AMP-Dependent Protein Kinases :: antagonists & inhibitors; Cyclic AMP-Dependent Protein Kinases :: metabolism; DNA-Binding Proteins :: drug effects; DNA-Binding Proteins :: metabolism; Enzyme Activation :: drug effects; Human; Interleukin-8 :: biosynthesis; Interleukin-8 :: genetics; Lung Neoplasms; NF-kappa B :: drug effects; NF-kappa B :: metabolism; Nuclear Proteins :: drug effects; Nuclear Proteins :: metabolism; Ozone :: toxicity; Protein Kinase C :: antagonists & inhibitors; Protein Kinase C :: metabolism; Protein-Tyrosine Kinase :: antagonists & inhibitors; Protein-Tyrosine Kinase :: metabolism; Reactive Oxygen Species :: physiology; Signal Transduction :: drug effects; Support, U.S. Gov't, Non-P.H.S. ; Support, U.S. Gov't, P.H.S. ; Transcription, Genetic :: drug effects; Tumor Cells, Cultured;
Hue Vuong,
Tricia Patterson,
Pavan Adiseshaiah,
Paul Shapiro,
Dhananjaya V Kalvakolanu,
Sekhar P M Reddy
Department of Environmental Health Sciences, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205, USA.
Exposure of distal bronchiolar region to various toxicants and pollutants suppresses Clara cell differentiation marker expression and greatly enhances the induction of squamous cell differentiation (SCD). Here, we demonstrate for the first time phorbol 13-myristate 12-acetate (PMA)-inducible expression of SCD markers, SPRRs, in Clara-like H441 cells. The transcriptional stimulation of human SPRR1B expression is mainly mediated by a -150- to -84-bp region that harbors two critical activator protein (AP)-1 sites. In unstimulated cells, the -150- to -84-bp region is weakly bound by AP-1 proteins, mainly JunD and Fra1. However, PMA prominently induced the binding of JunB and Fra1. Consistent with this, overexpression of wild-type Jun proteins upregulated the SPRR1B promoter activity. Conversely, a c-jun mutant suppressed both basal and PMA-inducible reporter gene expression. Intriguingly, overexpression of fra2 suppressed PMA-inducible reporter activity, whereas fra1 significantly enhanced basal level activity, indicating an opposing role for these proteins in SPRR1B expression in a manner similar to that observed in proximal tracheobronchial epithelial cells (BEAS-2B clone S6). Interestingly, unlike in S6 cells, a catalytically inactive c-Jun NH(2)-terminal kinase (JNK) 1 mutant significantly reduced the PMA-inducible SPRR1B promoter activity in H441 cells. Thus either temporal expression and/or spatial activation of AP-1 proteins by JNK1 might contribute to the induction of SCD in Clara cells.
Mesh-terms: Adenocarcinoma, Bronchiolo-Alveolar; Biological Markers; Carcinogens :: pharmacology; Cell Differentiation :: drug effects; Cell Differentiation :: physiology; Gene Expression :: drug effects; Gene Expression :: physiology; Human; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases :: metabolism; Mitogen-Activated Protein Kinases :: metabolism; Promoter Regions (Genetics):: physiology; Protein-Serine-Threonine Kinases :: metabolism; Proteins :: genetics; Proto-Oncogene Proteins c-raf :: metabolism; Support, U.S. Gov't, P.H.S. ; Tetradecanoylphorbol Acetate :: pharmacology; Transcription Factor AP-1 :: metabolism; Transcription, Genetic :: drug effects; Transcription, Genetic :: physiology; Tumor Cells, Cultured :: cytology; Tumor Cells, Cultured :: enzymology; p42 MAP Kinase :: metabolism; ras Proteins :: metabolism;
Dawn M Flaherty,
Sara L Hinde,
Martha M Monick,
Linda S Powers,
Mary A Bradford,
Timur Yarovinsky,
Gary W Hunninghake
Airway epithelial cells are often the sites of targeted adenovirus vector delivery. Activation of the host inflammatory response and modulation of signal transduction pathways by adenovirus vectors have been previously documented, including activation of MAP kinases and phosphatidylinositol 3-kinase (PI3-kinase). The effect of activation of these pathways by adenovirus vectors on cell survival has not been examined. Both the PI3-kinase/Akt and ERK/MAP kinase signaling pathways have been linked to cell survival. Akt has been found to play a role in cell survival and apoptosis through its downstream effects on apoptosis-related proteins. Constitutive activation of either PI3-kinase or Akt blocks apoptosis induced by c-Myc, UV radiation, transforming growth factor-beta, Fas, and respiratory syncytial virus infection. We examined the effect of adenovirus vector infection on activation of these prosurvival pathways and its downstream consequences. Airway epithelial cells were transduced with replication-deficient adenoviral vectors containing a nonspecific transgene, green fluorescent protein driven by the cytomegalovirus promoter, or an empty vector with no transgene. They were then exposed to the proapoptotic stimulus actinomycin D plus TNF-alpha, and evidence of apoptosis was evaluated. Compared with the cells treated with actinomycin/TNF alone, the adenovirus vector-infected cells had a 50% reduction in apoptosis. When we examined induction of the prosurvival pathways, ERK and AKT, in the viral vector-infected cells, we found that there was significant activation of both Akt and ERK.
Mesh-terms: Adenocarcinoma, Bronchiolo-Alveolar; Adenoviridae :: genetics; Antineoplastic Agents :: pharmacology; Apoptosis :: drug effects; Apoptosis :: physiology; Cell Line, Tumor; Cell Survival :: physiology; Gene Expression Regulation, Viral; Genetic Vectors :: physiology; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinases :: metabolism; Protein-Serine-Threonine Kinases :: metabolism; Proto-Oncogene Proteins :: metabolism; Proto-Oncogene Proteins c-akt; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S. ; Respiratory Mucosa :: cytology; Respiratory Mucosa :: physiology; Transcription, Genetic; Tumor Necrosis Factor-alpha :: pharmacology;
